US 12,295,967 B2
Pharmaceutical composition for prevention or treatment of flavivirus infection
Cheol Hee Won, Seoul (KR); and Dal Hee Min, Seoul (KR)
Assigned to LEMONEX INC., Seoul (KR); and SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION, Seoul (KR)
Appl. No. 17/051,117
Filed by LEMONEX INC., Seoul (KR); and SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, Seoul (KR)
PCT Filed Apr. 24, 2019, PCT No. PCT/KR2019/004974
§ 371(c)(1), (2) Date Oct. 27, 2020,
PCT Pub. No. WO2019/209035, PCT Pub. Date Oct. 31, 2019.
Claims priority of provisional application 62/663,312, filed on Apr. 27, 2018.
Claims priority of application No. 10-2019-0048075 (KR), filed on Apr. 24, 2019.
Prior Publication US 2021/0228607 A1, Jul. 29, 2021
Int. Cl. A61K 31/7036 (2006.01); A61K 31/282 (2006.01); A61K 31/47 (2006.01); A61K 31/4706 (2006.01); A61K 31/496 (2006.01); A61K 31/536 (2006.01); A61K 31/5415 (2006.01); A61K 31/546 (2006.01); A61K 31/661 (2006.01); A61K 31/7048 (2006.01); A61K 38/12 (2006.01); A61K 38/14 (2006.01); A61P 31/14 (2006.01)
CPC A61K 31/7036 (2013.01) [A61K 31/282 (2013.01); A61K 31/47 (2013.01); A61K 31/4706 (2013.01); A61K 31/496 (2013.01); A61K 31/536 (2013.01); A61K 31/5415 (2013.01); A61K 31/546 (2013.01); A61K 31/661 (2013.01); A61K 31/7048 (2013.01); A61K 38/12 (2013.01); A61K 38/14 (2013.01); A61P 31/14 (2018.01); C12Y 203/01059 (2013.01)] 15 Claims
 
1. A method for treating a flavivirus infection, the method comprising administering to a subject in need thereof a composition comprising:
at least one of paromomycin, capreomycin, thioridazine HCl, miltefosine, resminostat, nedaplatin and cephalothin; or at least one of pharmaceutically acceptable salts of the above compounds.